Breast Cancer Awareness Month will be here before you know it! To generate awareness and impact from August 1st through October 31st, BREVAGenplus will be offered at a promotional price of $199!
We are dedicated to assessing every qualified patient’s breast cancer risk through our validated genetic breast cancer risk assessment test for average risk women that have limited to no family history of Breast Cancer.
Contact your Healthcare Provider today and ask about BREVAGenplus!
- BREVAGenplus provides information about breast cancer risk over a 5 year period; it does not diagnose breast cancer
- BREVAGenplus is validated in African American, Caucasian, and Hispanic women age 35 years or older
- The risk estimate used in this test does not take into account several other breast cancer risk factors, such as an extensive family history of breast and ovarian cancer and thus does not provide a lifetime risk score
- This test is used for clinical purposes
* BREVAGenplus is not applicable to women who are already at high risk of breast cancer including those that have a personal or extensive family history of breast and/or ovarian cancer, LCIS, DCIS, AH or have thoracic RT under 30y. Any women with these risk factors are already at increased risk of breast cancer and should be screened and followed as such.